Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Receivables (2016 - 2025)

Cellectis (CLLS) has 6 years of Receivables data on record, last reported at $772000.0 in Q4 2022.

  • For Q4 2022, Receivables fell 96.21% year-over-year to $772000.0; the TTM value through Dec 2022 reached $772000.0, down 96.21%, while the annual FY2022 figure was $772000.0, 96.21% down from the prior year.
  • Receivables reached $772000.0 in Q4 2022 per CLLS's latest filing, down from $20.4 million in the prior quarter.
  • Across five years, Receivables topped out at $20.4 million in Q4 2021 and bottomed at $772000.0 in Q4 2022.
  • Average Receivables over 4 years is $7.6 million, with a median of $4.6 million recorded in 2018.
  • Peak YoY movement for Receivables: soared 252.34% in 2021, then tumbled 96.21% in 2022.
  • A 4-year view of Receivables shows it stood at $3.4 million in 2018, then surged by 72.59% to $5.8 million in 2020, then skyrocketed by 252.34% to $20.4 million in 2021, then crashed by 96.21% to $772000.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Receivables were $772000.0 in Q4 2022, $20.4 million in Q4 2021, and $5.8 million in Q4 2020.